Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
257 studies found for:    nichd AIDS/HIV

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Efavirenz;   Drug: Raltegravir
2 Completed
Has Results 		Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission
Conditions: Disease Transmission, Vertical;   Vertical Human Immunodeficiency Virus Transmission;   HIV Infections
Interventions: Drug: Zidovudine;   Drug: Nevirapine (NVP);   Drug: Epivir (3TC);   Drug: Nelfinavir (NFV)
3 Completed
Has Results 		Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents
Condition: HIV Infections
Interventions: Drug: ATV;   Drug: Ritonavir
4 Active, not recruiting Safety and Effectiveness of Oral Alendronate Therapy on Bone Mineral Density in HIV-infected Children and Adolescents With Low Bone Mineral Density
Condition: HIV Infections
Interventions: Drug: Alendronate;   Drug: Alendronate placebo;   Dietary Supplement: Calcium carbonate/vitamin D
5 Completed
Has Results 		Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
Condition: HIV Infections
Interventions: Drug: NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT);   Drug: NNRTIs (EFV, NVP);   Drug: PIs (AMP, IDV, LPV/r, NFV, SQV, RTV)
6 Completed Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lamivudine;   Drug: Lamivudine/Zidovudine;   Drug: Nelfinavir mesylate;   Drug: Nevirapine;   Drug: Zidovudine
7 Completed Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy
Condition: HIV Infections
Interventions: Biological: rMVA-HIV (env/gag [TBC-M358] + tat/rev/nef-RT [TBC-M335)]);   Biological: rFPV-HIV (env/gag [TBC-F357] + tat/rev/nef-RT [TBC-F349])
8 Completed A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers
Conditions: HIV Infections;   HIV Seronegativity
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Biological: MN rgp120/HIV-1 and GNE8 rgp120/HIV-1;   Biological: ALVAC-HIV MN120TMG (vCP205)
9 Completed Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs
Condition: HIV Infections
Interventions: Drug: Didanosine;   Drug: Efavirenz;   Drug: Emtricitabine
10 Completed Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
Condition: HIV Infections
Interventions: Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate
11 Completed A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome;   HIV Lipodystrophy Syndrome;   Lipodystrophy;   Dyslipidemia;   Osteoporosis;   Osteopenia
Intervention:
12 Active, not recruiting
Has Results 		Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents
Condition: HIV Infections
Interventions: Drug: Raltegravir poloxamer film coated tablet;   Drug: Raltegravir chewable tablet;   Drug: Raltegravir oral granules for suspension (20 mg/mL)
13 Completed Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants
Condition: HIV Infections
Intervention: Drug: Lopinavir/Ritonavir
14 Completed
Has Results 		Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth
Conditions: HIV Infections;   H1N1 Influenza Virus
Intervention: Biological: Influenza A (H1N1) 2009 monovalent vaccine
15 Completed Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems
Condition: HIV Infections
Interventions: Biological: Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed;   Biological: Diphtheria and Tetanus Toxoids Adsorbed;   Biological: Tetanus and Diphtheria Toxoids Adsorbed;   Drug: Bacteriophage phi X 174;   Drug: Aldesleukin
16 Completed
Has Results 		Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Vicriviroc
17 Completed
Has Results 		Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Biological: Quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle (VLP) or Quadrivalent human papillomavirus vaccine (QHPV);   Other: Placebo/QHPV
18 Completed A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Zidovudine
19 Completed A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
Condition: HIV
Intervention:
20 Completed A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Lamivudine;   Drug: Zidovudine
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years